Filter your search
- $995.00 – $1,900.00As Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies […]July 1, 2009$995.00 – $1,900.00The information represented in this report is a comprehensive analysis of the eye care market globally with a special focus on the United States and selected international sectors. The year ending December 31, 2008 was used as the base year with forecasts to the year 2013. Market statistics are given in U.S. dollars and in […]July 1, 2009$3,995.00 – $7,990.00The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used […]June 1, 2009$3,500.00 – $7,000.00New technologies are transforming patient monitoring and Kalorama Information has reported on these developments last year. This report, High-Tech Patient Monitoring market updates revenues and segment breakdowns to reflect changes in the market, particularly the remote monitoring and the enhanced role of applications to transfer patient data to EMR systems. Advances in remote patient monitoring […]June 1, 2009$250.00 – $1,600.00The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama’s lead analyst, Shara Rosen. Regardless […]May 1, 2009$995.00 – $7,990.00Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, […]May 1, 2009$995.00 – $7,000.00While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of this decade there was a delcine […]May 1, 2009$250.00 – $3,395.00It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information’s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen’s new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America […]May 1, 2009$1,500.00 – $9,000.00Kalorama Information’s 300 page Worldwide Wound Care: Total Market Coverage report represents the full contents of the Kalorama three-volume 2009 wound care series. The reports are joined in one volume to offer a better value to the customer that wants total market coverage. Kalorama’s approach differs from other published reports in that we segment the […]May 1, 2009$2,995.00 – $5,990.00There are millions of surgical procedures performed annually worldwide and the market for wound care products and techniques is significant. Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area and thus an important market. Kalorama Information’s Wound Care Series offers one of the most complete […]May 1, 2009
